• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Sciences

    Stereotaxis Announces FDA Clearance & Launch of Synchrony System

    GLOBENEWSWIRE

    Klinikum Fürth Launches Premier Robotic Heart Arrhythmia Program

    GLOBENEWSWIRE

    Stereotaxis Receives FDA Approval For Magic Ablation Catheter

    GLOBENEWSWIRE

    Genesisx Robotic Magnetic Navigation System Cleared By FDA

    GLOBENEWSWIRE

    Stereotaxis Launches Synchrony System In EU Submits 510(K)

    GLOBENEWSWIRE

    Erasmus Med. Center Enhances Cardio Care With Genesis Robotic

    GLOBENEWSWIRE

    First US Robotic HD Mapping Done With MAGiC Sweep Catheter

    GLOBENEWSWIRE

    Stereotaxis Gets FDA Clearance for MAGiC Sweep Catheter

    GLOBENEWSWIRE

    MAGiC Catheter Study Results Published in Cardio Journal

    GLOBENEWSWIRE

    Stereotaxis to Demo GenesisX Robotic System at HRS 2025

    GLOBENEWSWIRE

    Stereotaxis Highlighted By NVIDIA & Joins Connect Program

    GLOBENEWSWIRE

    Stereotaxis Seeks Nod For First Robotically Navigated EP Catheter

    GLOBENEWSWIRE

    Stereotaxis Seeks Clearance For EMAGIN Robotic Catheter

    GLOBENEWSWIRE

    Stereotaxis to Present at TD Cowen Healthcare Conference

    GLOBENEWSWIRE

    Stereotaxis Announces First GenesisX Robotic System Order

    GLOBENEWSWIRE

    Stereotaxis Receives CE Mark Approval for MAGiC Ablation Catheter

    GLOBENEWSWIRE

    Oulu Hospital Enhances Arrhythmia Care With Genesis Robotic Tech

    GLOBENEWSWIRE

    Magbot Robotic Magnetic Navigation Catheter Approved by China NMPA

    GLOBENEWSWIRE

    Hospital Da Luz First In Portugal To Adopt Genesis Robotic System

    GLOBENEWSWIRE

    University of Kansas Enhances Robotic Heart Care with Genesis Tech

    GLOBENEWSWIRE

    Stereotaxis Featured At Annual Meeting Of Cardiac Robotic Navigation

    GLOBENEWSWIRE

    Stereotaxis to Present at Upcoming Investor Conferences

    GLOBENEWSWIRE

    Stereotaxis Gets CE Mark For GenesisX, Submits 510(k) In US

    GLOBENEWSWIRE

    Corewell Health Grows Robotic Program to Treat Heart Rhythm Disorders

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.